{"filing":{"accession_number":"0001683168-26-005806","cik":"0001956955","ticker":"UMAC","company_name":"Unusual Machines, Inc.","form":"8-K","filing_date":"2026-07-28","report_date":"2026-07-24","primary_document":"umac_8k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1956955/000168316826005806/umac_8k.htm"},"events":[{"id":21029,"run_id":18951,"accession_number":"0001683168-26-005806","anchor_item_number":"5.02","event_type":"exec_compensation","event_domain":"governance","is_material":true,"confidence":0.95,"summary":"The filing discloses compensatory arrangements approved by the Compensation Committee on July 24, 2026, including a warrant grant to CEO Dr. Allan Evans (5,000,000 shares at $25.00 exercise price, vesting upon stock price targets) and stock option grants to three executive officers (Andrew Camden, Brian Hoff, and Stacy Wright). The CEO's arrangement is particularly material as it involves a substantial equity grant coupled with a waiver of all cash compensation following December 31, 2026. This is a classic Item 5.02(e) disclosure of executive compensation arrangements.","company_name":"Unusual Machines, Inc.","ticker":"UMAC","filing_date":"2026-07-28","form":"8-K","submitted_at":null,"items":[{"id":20560,"accession_number":"0001683168-26-005806","item_number":"5.02","item_title":"Departure of Directors or Principal Officers;","event_type":"exec_compensation","event_domain":"governance","is_material":true,"confidence":0.95,"reasoning":"The filing discloses compensatory arrangements approved by the Compensation Committee on July 24, 2026, including a warrant grant to CEO Dr. Allan Evans (5,000,000 shares at $25.00 exercise price, vesting upon stock price targets) and stock option grants to three executive officers (Andrew Camden, Brian Hoff, and Stacy Wright). The CEO's arrangement is particularly material as it involves a substantial equity grant coupled with a waiver of all cash compensation following December 31, 2026. This is a classic Item 5.02(e) disclosure of executive compensation arrangements.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-28T20:02:58.729848+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":20560,"accession_number":"0001683168-26-005806","item_number":"5.02","item_title":"Departure of Directors or Principal Officers;","event_type":"exec_compensation","event_domain":"governance","is_material":true,"confidence":0.95,"reasoning":"The filing discloses compensatory arrangements approved by the Compensation Committee on July 24, 2026, including a warrant grant to CEO Dr. Allan Evans (5,000,000 shares at $25.00 exercise price, vesting upon stock price targets) and stock option grants to three executive officers (Andrew Camden, Brian Hoff, and Stacy Wright). The CEO's arrangement is particularly material as it involves a substantial equity grant coupled with a waiver of all cash compensation following December 31, 2026. This is a classic Item 5.02(e) disclosure of executive compensation arrangements.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-28T20:02:58.729848+00:00","company_name":"Unusual Machines, Inc.","ticker":"UMAC","filing_date":"2026-07-28"}]}